These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
303 related articles for article (PubMed ID: 25997858)
1. Synthesis of (68)Ga-labeled NOTA-RGD-GE11 heterodimeric peptide for dual integrin and epidermal growth factor receptor-targeted tumor imaging. Yu HM; Chen JH; Lin KL; Lin WJ J Labelled Comp Radiopharm; 2015 Jun; 58(7):299-303. PubMed ID: 25997858 [TBL] [Abstract][Full Text] [Related]
2. Chen CJ; Chan CH; Lin KL; Chen JH; Tseng CH; Wang PY; Chien CY; Yu HM; Lin WJ Nucl Med Biol; 2019; 68-69():22-30. PubMed ID: 30578136 [TBL] [Abstract][Full Text] [Related]
3. Integrin α Li H; Peng W; Zhen Z; Zhang W; Liao S; Wu X; Wang L; Xuan A; Gao Y; Xu J Nucl Med Biol; 2023; 124-125():108364. PubMed ID: 37591041 [TBL] [Abstract][Full Text] [Related]
4. (68)Ga-labeled NOTA-RGD-BBN peptide for dual integrin and GRPR-targeted tumor imaging. Liu Z; Niu G; Wang F; Chen X Eur J Nucl Med Mol Imaging; 2009 Sep; 36(9):1483-94. PubMed ID: 19360404 [TBL] [Abstract][Full Text] [Related]
5. Preparation of a promising angiogenesis PET imaging agent: 68Ga-labeled c(RGDyK)-isothiocyanatobenzyl-1,4,7-triazacyclononane-1,4,7-triacetic acid and feasibility studies in mice. Jeong JM; Hong MK; Chang YS; Lee YS; Kim YJ; Cheon GJ; Lee DS; Chung JK; Lee MC J Nucl Med; 2008 May; 49(5):830-6. PubMed ID: 18413379 [TBL] [Abstract][Full Text] [Related]
6. A heterodimeric [RGD-Glu-[(64)Cu-NO2A]-6-Ahx-RM2] αvβ3/GRPr-targeting antagonist radiotracer for PET imaging of prostate tumors. Durkan K; Jiang Z; Rold TL; Sieckman GL; Hoffman TJ; Bandari RP; Szczodroski AF; Liu L; Miao Y; Reynolds TS; Smith CJ Nucl Med Biol; 2014 Feb; 41(2):133-9. PubMed ID: 24480266 [TBL] [Abstract][Full Text] [Related]
7. MicroPET/CT imaging of αvβ₃ integrin via a novel ⁶⁸Ga-NOTA-RGD peptidomimetic conjugate in rat myocardial infarction. Menichetti L; Kusmic C; Panetta D; Arosio D; Petroni D; Matteucci M; Salvadori PA; Casagrande C; L'Abbate A; Manzoni L Eur J Nucl Med Mol Imaging; 2013 Aug; 40(8):1265-74. PubMed ID: 23674206 [TBL] [Abstract][Full Text] [Related]
8. Preclinical evaluation of a dual sstr2 and integrin α Liu B; Zhang Z; Wang H; Yao S Bioorg Med Chem; 2019 Nov; 27(21):115094. PubMed ID: 31540828 [TBL] [Abstract][Full Text] [Related]
9. 64Cu-NO2A-RGD-Glu-6-Ahx-BBN(7-14)NH2: a heterodimeric targeting vector for positron emission tomography imaging of prostate cancer. Jackson AB; Nanda PK; Rold TL; Sieckman GL; Szczodroski AF; Hoffman TJ; Chen X; Smith CJ Nucl Med Biol; 2012 Apr; 39(3):377-87. PubMed ID: 22226021 [TBL] [Abstract][Full Text] [Related]
10. Imaging integrin αvβ 3 and NRP-1 positive gliomas with a novel fluorine-18 labeled RGD-ATWLPPR heterodimeric peptide probe. Wu H; Chen H; Pan D; Ma Y; Liang S; Wan Y; Fang Y Mol Imaging Biol; 2014 Dec; 16(6):781-92. PubMed ID: 25001194 [TBL] [Abstract][Full Text] [Related]
11. (18)F, (64)Cu, and (68)Ga labeled RGD-bombesin heterodimeric peptides for PET imaging of breast cancer. Liu Z; Yan Y; Liu S; Wang F; Chen X Bioconjug Chem; 2009 May; 20(5):1016-25. PubMed ID: 20540537 [TBL] [Abstract][Full Text] [Related]
12. (68)Ga-labeled multimeric RGD peptides for microPET imaging of integrin alpha(v)beta (3) expression. Li ZB; Chen K; Chen X Eur J Nucl Med Mol Imaging; 2008 Jun; 35(6):1100-8. PubMed ID: 18204838 [TBL] [Abstract][Full Text] [Related]
14. (68)Ga-labeled cyclic RGD dimers with Gly3 and PEG4 linkers: promising agents for tumor integrin alphavbeta3 PET imaging. Liu Z; Niu G; Shi J; Liu S; Wang F; Liu S; Chen X Eur J Nucl Med Mol Imaging; 2009 Jun; 36(6):947-57. PubMed ID: 19159928 [TBL] [Abstract][Full Text] [Related]
15. [(68)Ga]FSC-(RGD)3 a trimeric RGD peptide for imaging αvβ3 integrin expression based on a novel siderophore derived chelating scaffold-synthesis and evaluation. Knetsch PA; Zhai C; Rangger C; Blatzer M; Haas H; Kaeopookum P; Haubner R; Decristoforo C Nucl Med Biol; 2015 Feb; 42(2):115-22. PubMed ID: 25459110 [TBL] [Abstract][Full Text] [Related]
16. Evaluation of an Integrin α Gai Y; Jiang Y; Long Y; Sun L; Liu Q; Qin C; Zhang Y; Zeng D; Lan X Mol Pharm; 2020 Jan; 17(1):349-358. PubMed ID: 31829615 [TBL] [Abstract][Full Text] [Related]
17. [⁶⁸Ga]NS₃-RGD and [⁶⁸Ga] Oxo-DO3A-RGD for imaging α(v)β₃ integrin expression: synthesis, evaluation, and comparison. Knetsch PA; Petrik M; Rangger C; Seidel G; Pietzsch HJ; Virgolini I; Decristoforo C; Haubner R Nucl Med Biol; 2013 Jan; 40(1):65-72. PubMed ID: 23102540 [TBL] [Abstract][Full Text] [Related]
18. Ligands for mapping alphavbeta3-integrin expression in vivo. Schottelius M; Laufer B; Kessler H; Wester HJ Acc Chem Res; 2009 Jul; 42(7):969-80. PubMed ID: 19489579 [TBL] [Abstract][Full Text] [Related]
19. Novel Lucente E; Liu H; Liu Y; Hu X; Lacivita E; Leopoldo M; Cheng Z Bioconjug Chem; 2018 May; 29(5):1595-1604. PubMed ID: 29587479 [TBL] [Abstract][Full Text] [Related]
20. Small-animal PET of tumors with (64)Cu-labeled RGD-bombesin heterodimer. Liu Z; Li ZB; Cao Q; Liu S; Wang F; Chen X J Nucl Med; 2009 Jul; 50(7):1168-77. PubMed ID: 19525469 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]